Related Experiment Video
Updated: Jan 23, 2026

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
Published on: February 25, 2007
Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis
Zahra Tavakoli Dargani1, Dinender K Singla1
1Division of Metabolic and Cardiovascular Sciences, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida.
Abstract:
Doxorubicin (Dox)-induced cardiac side effects are regulated through increased oxidative stress and apoptosis. However, it remains unknown whether Dox induces the specific inflammatory-mediated form of cell death called pyroptosis. The current study is undertaken to determine whether Dox induces pyroptosis in an in vitro model and to test the potential of exosomes derived from embryonic stem cells (ES-Exos) in inhibiting pyroptosis. H9c2 cells were exposed to Dox to generate pyroptosis and then subsequently treated with exosomes to investigate the protective effects of ES-Exos. Mouse embryonic fibroblast-exosomes (MEF-Exos) were used as a cell line control. We confirmed pyroptosis by analyzing the presence of Toll-like receptor 4 (TLR4)-pyrin domain containing-3 (NLRP3) inflammasome that initiates pyroptosis, which was further confirmed with pyroptotic markers caspase-1, IL-1β, caspase-11, and gasdermin-D. The presence of inflammation was confirmed for proinflammatory cytokines, TNF-α, and IL-6. Our data show that Dox exposure significantly (P < 0.05) increases expression of TLR4, NLRP3, pyroptotic markers (caspase-1, IL-1β, caspase-11, and gasdermin-D), and proinflammatory cytokines (TNF-α and IL-6) in H9c2 cells. The increased expression of inflammasome, pyroptosis, and inflammation was significantly (P < 0.05) inhibited by ES-Exos. Interestingly, our cell line control, MEF-Exos, did not show any protective effects. Furthermore, our cytokine array data suggest increased anti-inflammatory (IL-4, IL-9, and IL-13) and decreased proinflammatory cytokines (Fas ligand, IL-12, and TNF-α) in ES-Exos, suggesting that anti-inflammatory cytokines might be mediating the protective effects of ES-Exos. In conclusion, our data show that Dox induces pyroptotic cell death in the H9c2 cell culture model and is attenuated via treatment with ES-Exos.NEW & NOTEWORTHY Doxorubicin (Dox)-induced cardiotoxicity is mediated through increased oxidative stress, apoptosis, and necrosis. We report for the first time as per the best of our knowledge that Dox initiates Toll-like receptor 4 and pyrin domain containing-3 inflammasome formation and induces caspase-1-mediated inflammatory pyroptotic cell death in H9c2 cells. Moreover, we establish that inflammation and pyroptosis is inhibited by embryonic stem cell-derived exosomes that could be used as a future therapeutic option to treat Dox-induced cardiotoxicity.
Insights
Doxorubicin induces pyroptosis, a form of inflammatory cell death, in H9c2 cells. Embryonic stem cell-derived exosomes (ES-Exos) effectively inhibit this pyroptosis and inflammation, offering a potential therapeutic strategy for Doxorubicin-induced cardiotoxicity.
Area of Science:
- Cardiology
- Cell Biology
- Immunology
Background:
- Doxorubicin (Dox) causes cardiotoxicity via oxidative stress and apoptosis.
- The role of pyroptosis, an inflammatory cell death, in Dox-induced cardiotoxicity is not well understood.
- Embryonic stem cell-derived exosomes (ES-Exos) are being investigated for therapeutic potential.
Purpose of the Study:
- To determine if Dox induces pyroptosis in H9c2 cells.
- To investigate the inhibitory effect of ES-Exos on Dox-induced pyroptosis and inflammation.
- To explore the underlying mechanisms of ES-Exos' protective effects.
Main Methods:
- H9c2 cells were treated with Dox to induce pyroptosis.
- ES-Exos and mouse embryonic fibroblast-exosomes (MEF-Exos) were used to assess protective effects.
- Pyroptosis was confirmed by analyzing Toll-like receptor 4 (TLR4)-pyrin domain containing-3 (NLRP3) inflammasome components (caspase-1, IL-1β, caspase-11, gasdermin-D) and proinflammatory cytokines (TNF-α, IL-6).
- Cytokine arrays were used to analyze changes in anti-inflammatory and proinflammatory cytokines.
Main Results:
- Dox exposure significantly increased the expression of TLR4, NLRP3 inflammasome, pyroptotic markers, and proinflammatory cytokines in H9c2 cells.
- ES-Exos significantly inhibited the Dox-induced increase in inflammasome, pyroptosis, and inflammation.
- MEF-Exos did not exhibit protective effects.
- ES-Exos treatment led to increased anti-inflammatory cytokines (IL-4, IL-9, IL-13) and decreased proinflammatory cytokines (Fas ligand, IL-12, TNF-α).
Conclusions:
- Doxorubicin induces pyroptotic cell death in H9c2 cells.
- ES-Exos attenuate Dox-induced pyroptosis and inflammation, suggesting a therapeutic role in mitigating Dox-induced cardiotoxicity.
- The anti-inflammatory properties of ES-Exos likely mediate their protective effects.
Related Concept Videos
Embryonic Stem Cells
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Adult Stem Cells
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...

